Published in J Immunol on May 01, 1976
Differentiation of memory T cells to virus plaque-forming cells and cytotoxic T lymphocytes. J Exp Med (1977) 1.04
Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells. Immunology (1978) 0.98
Direct cytotoxicity against chicken erythrocytes in mice. III. Degrees of radiosensitivity and cross-reactivity of cytotoxicity, delayed hypersensitivity and antibody production. Immunology (1979) 0.78
Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining Moloney sarcomas. Br J Cancer (1978) 0.75
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature (1985) 9.94
Modulation of inflammation and immunity by cyclic AMP. Science (1974) 4.31
Interleukin-2 augments natural killer cell activity. Nature (1981) 4.15
The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol (1972) 3.51
The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Nature (1987) 2.68
BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro. J Immunol (1978) 2.60
Cell-mediated immunity and antibody responses in the respiratory tract after local and systemic immunization. J Exp Med (1971) 2.54
Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells. J Immunol (1971) 2.38
Origin and differentiation of lymphocytes involved in the secretory IgA responses. Cold Spring Harb Symp Quant Biol (1977) 2.09
Demonstration of the exposure of new antigenic determinants following antigen-antibody combination. Nature (1965) 2.04
In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol (1983) 1.97
Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest (1973) 1.94
Introduction of "natural" killer' cells by BCG. Nature (1976) 1.88
The role of cyclic AMP in the cytolytic activity of lymphocytes. J Immunol (1971) 1.78
Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. J Immunol (1983) 1.72
Cell-mediated immunity shown by lymphocytes from the respiratory tract. Science (1970) 1.71
Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J Immunol (1981) 1.70
Studies on the mechanism of lymphocyte-mediated cytolysis. II. The use of various target cell markers to study cytolytic events. J Immunol (1973) 1.69
Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. J Immunol (1980) 1.68
The effects of a series of prostaglandins on in vitro models of the allergic response and cellular immunity. Prostaglandins (1972) 1.67
Studies on the mechanism of lymphocyte-mediated cytolysis. IV. Specificity of the histamine receptor on effector T cells. J Immunol (1973) 1.63
The reactivity of rheumatoid factor with human gamma G globulin. Immunology (1965) 1.62
BCG-induced murine effector cells. II. Characterization of natural killer cells in peritoneal exudates. J Immunol (1977) 1.56
The differentiation of cytotoxic T cells in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent. J Immunol (1979) 1.56
Molecular characterization of interleukin 2. Immunol Rev (1982) 1.52
Functional heterogeneity of murine lymphoid cells. IV. Allogeneic mixed lymphocyte reactivity and cytolytic activity as functions of distinct T cell subsets. J Immunol (1973) 1.47
Properties of a subpopulation of T cells bearing histamine receptors. J Clin Invest (1975) 1.43
The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines. J Immunol (1981) 1.42
On the mechanism of T-cell mediated cytolysis. Transplant Rev (1973) 1.42
T-Cell-mediated cytolysis: an overview of some current issues. Contemp Top Immunobiol (1977) 1.35
Studies on the mechanism of lymphocyte-mediated cytolysis. VI. A reappraisal of the requirement for protein synthesis during T cell-mediated lysis. J Immunol (1976) 1.32
Interleukin 7: effects on early events in lymphopoiesis. Immunol Today (1989) 1.32
Studies on the mechanism of lymphocyte-mediated cytolysis. 3. The role of microfilaments and microtubules. J Immunol (1973) 1.31
Selective depletion of NK cell activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants. Int J Cancer (1982) 1.30
Effect of antigen on the structural configuration of homologous antibody following antigen-antibody combination. Nature (1966) 1.29
Studies on the mechanism of lymphocyte-mediated cytolysis. IX. Relationships between antigen recognition and lytic expression in killer T cells. J Immunol (1977) 1.28
Evidence for direct linkage between antigen recognition and lytic expression in effector T cells. J Exp Med (1976) 1.28
A simplified procedure for the preparation of immunoglobulin-class-specific antisera. J Immunol (1969) 1.26
Lymphokine-driven "differentiation" of cytotoxic T-cell clones into cells with NK-like specificity: correlations with display of membrane macromolecules. Immunol Rev (1983) 1.26
Characterization of five cloned murine cell lines showing high cytolytic activity against YAC-1 cells. J Immunol (1982) 1.20
Studies on human IgD. II. The lack of skin sensitizing and complement fixing activities of immunoglobulin D. Immunochemistry (1969) 1.20
Glycolipid expression in lymphoma cell variants: chemical quantity, immunologic reactivity, and correlations with susceptibility to NK cells. J Immunol (1981) 1.20
Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells. J Immunol (1975) 1.20
Antigen-T lymphocyte interactions: inhibition by cytochalasin B. J Immunol (1973) 1.19
Studies of the mechanism of lymphocyte-mediated cytolysis. VII. Two stages in the T cell-mediated lytic cycle with distinct cation requirements. J Immunol (1976) 1.18
Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action. J Immunol (1982) 1.18
The biochemical and biological characterization of lymphocyte regulatory molecules. VI. Generation of a B cell hybridoma whose antibody product inhibits interleukin 2 activity. J Immunol (1981) 1.16
Immune response of the human respiratory tract. II. Cell-mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses. J Infect Dis (1973) 1.10
Increase in histamine receptors on thymus-derived effector lymphocytes during the primary immune response to alloantigens. Nature (1973) 1.10
Effect of anti-lymphotoxin on cell-mediated cytotoxicity. Evidence for two pathways, one involving lymphotoxin and the other requiring intimate contact between the plasma membranes of killer and target cells. Cell Immunol (1976) 1.09
The effect of capping H-2 antigens on the susceptibility of target cells to humoral and T cell-mediated lysis. Nat New Biol (1973) 1.09
Studies on the mechanism of lymphocyte-mediated cytolysis. XI. The role of lectin in lectin-dependent cell-mediated cytotoxicity. J Immunol (1978) 1.09
Antigenic determinants specific for aggregated gamma G-globulins. J Immunol (1968) 1.09
Structural and conformational specificity of the antigen for rheumatoid factor. Ann N Y Acad Sci (1969) 1.07
Monoclonal antibody directed against interleukin 2. I. Inhibition of T lymphocyte mitogenesis and the in vitro differentiation of alloreactive cytolytic T cells. J Exp Med (1981) 1.06
Studies on the mechanism of lymphocyte-mediated cytolysis. V. The use of cytochalasins A and B to dissociate glucose transport from the lytic event. J Immunol (1975) 1.06
Studies on the cytotoxic activity of human lymphocytes. II. Interactions between IgG and Fc receptors leading to inhibition of K cell function. J Immunol (1977) 1.04
Studies on the immunogenicity of antigen-antibody precipitates. 1. The suppressive effect of anti-L and anti-H chain antibodies on the immunogenicity of human gammaG globulin. J Immunol (1968) 1.04
BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG. J Immunol (1977) 1.03
The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens. J Exp Med (1979) 1.03
Studies on the mechanism of lymphocyte-mediated cytolysis. I. The role of divalent cations in cytolysis by T lymphocytes. J Immunol (1973) 1.02
Interleukin 2 is not sufficient for the continuous growth of cloned NK-like cytotoxic cell lines. J Immunol (1983) 1.02
A cytolytic system for the in vitro detection of cell-mediated immunity to soluble antigen. J Immunol (1970) 1.01
Studies on T cell clonal expansion. I. Suppression of killer T cell production in vivo. J Immunol (1975) 1.01
In vivo suppression of the immune response to alloantigen by cholera enterotoxin. J Clin Invest (1973) 1.01
Characterization of a lymphoma cell variant selectively resistant to natural killer cells. J Immunol (1980) 1.00
Liposomes as model membrane systems for immune attack. I. Transfer of antigenic determinants to lymphocyte membranes after interactions with hapten-bearing liposomes. J Immunol (1978) 1.00
On the relation of products of activated lymphocytes to cell-mediated cytolysis. J Exp Med (1974) 0.99
Generation of H-2 restricted cytotoxic T cells by trinitrophenylated proteins in vitro: specificity and requirements. J Immunol (1979) 0.99
The secretory immunoglobulin A response in the gut [proceedings]. Biochem Soc Trans (1977) 0.98
Estimation of the size of a T-cell-induced lytic lesion. Nature (1974) 0.98
Studies on the cytolytic activity of human lymphocytes. III. An analysis of requirements for K cell-target interaction. J Immunol (1977) 0.98
T cell mediated cytolysis: consideration of the role of a soluble mediator. J Reticuloendothel Soc (1975) 0.97
Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo. J Immunol (1984) 0.97
Antibody-dependent cytolytically active human leukocytes: an analysis of inactivation following in vitro interaction with antibody-coated target cells. J Immunol (1975) 0.96
Kinetic analysis of target cell destruction by effector T cells. I. Delineation of parameters related to the frequency and lytic efficiency of killer cells. J Immunol (1976) 0.95
NK cell-target interactions: approaches towards definition of recognition structures. Cancer Metastasis Rev (1982) 0.94
Studies on the mechanism of suppression of the immune response by antibody. Int Arch Allergy Appl Immunol (1971) 0.94
Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor. J Immunol (1975) 0.94
An antigenic determinant of human gamma-globulin susceptible to papain digestion. J Immunol (1967) 0.93
Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. J Immunol (1980) 0.93
Heterogeneity in antibodies specific for aggregated human gammaG-globulin. J Immunol (1968) 0.93
An analysis of the natural killer cell defect in beige mice. Cell Immunol (1981) 0.92
Display of the neutral glycolipid ganglio-n-tetraosylceramide (asialo GM1) on cells of the natural killer and T lineages. Transplantation (1982) 0.92
Limiting dilution analysis of interleukin 2 and colony-stimulating factor producer cells in normal and autoimmune mice. J Immunol (1984) 0.92
B-lymphocyte mediated cytolysis: a complement independent phenomenon. Immunol Commun (1972) 0.92
Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell. J Immunol (1979) 0.92
The treatment of induced immune deficiency with interleukin-2. Immunol Lett (1985) 0.91
Immunomodulatory properties of porins of some members of the family Enterobacteriaceae. Infect Immun (1997) 0.89
Adverse reactions following administration of human gamma globulin. J Allergy (1969) 0.89
The specificity of the early immune response. I. A comparison of the specificity of delayed hypersensitivity and humoral responses following immunization with human gammaG globulin. J Immunol (1969) 0.87
Flour mill lung: a pneumoconiosis of mixed aetiology. Indian J Chest Dis Allied Sci (2002) 0.87
The differentiation of cytotoxic T cells in vitro. IV. Interleukin-2 production in primary mixed lymphocyte cultures involves cooperation between Qa-1+ and Qa-1- "helper" T cells. J Immunol (1981) 0.87
Some biological activities associated with the 10S form of human gamma-G-globulin. Immunology (1967) 0.86
Studies on single radial immunodiffusion techniques for the quantitation of antigen and antibody. J Immunol Methods (1972) 0.86
The secretory IgA system of the gut. Ciba Found Symp (1978) 0.85